发明名称 Use of thromboxane A2 antagonists for the manufacture of a medicament for improving post-ischemic myocardial dysfunction.
摘要 <p>A method is provided for improving post-ischemic myocardial dysfunction such as contractile dysfunction or reperfusion injury by administering a thromboxane A2 antagonist before, during or immediately after an ischemic attack.</p>
申请公布号 EP0309801(A2) 申请公布日期 1989.04.05
申请号 EP19880114866 申请日期 1988.09.12
申请人 E.R. SQUIBB & SONS, INC. 发明人 GROVER, GARY JAMES;FULMOR, IRVIN EDGAR III
分类号 A61K31/19;A61K31/34;A61K31/557;A61K45/00;A61P9/04;A61P9/08;A61P9/10;C07D493/08 主分类号 A61K31/19
代理机构 代理人
主权项
地址